Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere

东半球免疫遗传多样性的演变和功能

基本信息

  • 批准号:
    10365232
  • 负责人:
  • 金额:
    $ 79.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-11 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT Human leukocyte antigens (HLA) and killer cell immunoglobulin-like receptors (KIR) are critical facets of the human immune system. Interactions of KIR, expressed by natural killer cells (NK cells), with HLA class I, expressed by most tissue cells, modulate immune cell functions. Variations in the highly polymorphic KIR and HLA genes are linked directly to NK cell functions and have profound impact on human health, including associations with autoimmunity and neurological disease, severity of infectious disease, pregnancy syndromes, and risk of cancer. Our ability to resolve the mechanisms of immune-mediated disease, to develop personalized medicines, including immunotherapies, and to match organ donors with recipients relies on our ability to accurately characterize KIR and HLA class I diversity. Despite this crucial importance, there is a lack of knowledge concerning the extent and nature of KIR and HLA class I diversity worldwide. This deficit includes the Eastern Hemisphere, which encompasses half the world's population, and multiple underrepresented groups in the USA. During this project we will fill these gaps in this knowledge through determining the characteristics and functional consequences of KIR and HLA class I diversity across the entire Eastern Hemisphere. We will examine 15,612 individuals representing 51 discrete populations, including indigenous populations from East Asia, South Asia, multiple Pacific Islands and Oceania. To overcome difficulties in analyzing these complex genomic regions, we developed a targeted sequencing and bioinformatics approach to analyze KIR and HLA class I genes at high throughput and resolution. To analyze an additional 22,905 individuals, we will develop an imputation algorithm to determine high-resolution KIR alleles from whole-genome SNP data. We will construct imputation panels specifically for these populations who have been neglected in previous analyses. This goal will be made possible through the extensive training data generated. We will then characterize the distribution of KIR and HLA haplotypes across the Eastern Hemisphere. We will examine how the geographic patterns of KIR and HLA diversity have been shaped by natural selection and investigate the impact of adaptive introgression and admixture specifically focused to the KIR and HLA loci in our study populations. We will determine the functional properties of those variants we have identified as targeted by natural selection. We will pursue these aims implementing innovative laboratory and analytical tools. These developments include CRISPR/cas9 targeting of long-read sequencing to examine KIR structural diversity, and methods both to identify alleles subject to natural selection, and the mode of selection acting on them. The expected outcome of this work is the genetic and functional characterization of HLA and KIR across multiple human populations, and a comprehensive understanding of how this variation is geographically distributed and shaped by natural selection. This work will benefit investigations of immune-mediated and infectious disease and in establishment of personalized treatments for individuals both in the USA and worldwide.
摘要 人类白细胞抗原(HLA)和杀伤细胞免疫球蛋白样受体(KIR)是免疫球蛋白的重要方面。 人体免疫系统由自然杀伤细胞(NK细胞)表达的KIR与HLA I类的相互作用, 由大多数组织细胞表达,调节免疫细胞功能。高度多态性的KIR和 HLA基因与NK细胞功能直接相关,对人类健康有深远影响,包括 与自身免疫和神经系统疾病、感染性疾病严重程度、妊娠相关 综合症和癌症风险。我们解决免疫介导疾病机制的能力, 个性化的药物,包括免疫疗法,并匹配器官捐赠者与受体依赖于我们的 准确表征KIR和HLA I类多样性的能力。尽管这一点至关重要,但缺乏 关于KIR和HLA I类多样性的程度和性质的知识。这一赤字包括 东半球占世界人口的一半, 在美国的团体。在本项目中,我们将通过确定 整个东部地区KIR和HLA I类多样性的特征和功能后果 半球 我们将研究代表51个离散种群的15,612个个体,包括土著种群 来自东亚、南亚、多个太平洋岛屿和大洋洲。为了克服分析这些问题的困难, 复杂的基因组区域,我们开发了一种靶向测序和生物信息学方法来分析KIR 和HLA-I类基因。为了分析另外22,905人,我们将 开发一种插补算法,从全基因组SNP数据中确定高分辨率KIR等位基因。我们 我将专门为这些在以前的研究中被忽视的人群构建插补小组。 分析。这一目标将通过生成的大量培训数据得以实现。然后我们将 描述KIR和HLA单倍型在东半球的分布。 我们将研究自然选择如何塑造KIR和HLA多样性的地理模式 研究适应性基因渗入和混合对KIR和HLA基因座的影响 in our study研究populations人群.我们将确定我们已确定的这些变体的功能特性 是自然选择的目标我们将努力实现这些目标, 工具.这些进展包括CRISPR/cas9靶向长读序测序,以检查KIR结构, 多样性,以及鉴定受自然选择影响的等位基因的方法,以及选择作用于 他们这项工作的预期结果是HLA和KIR的遗传和功能特征, 多个人群,并全面了解这种变化是如何在地理上 由自然选择分布和塑造。这项工作将有利于免疫介导的研究, 传染病和建立个性化治疗的个人都在美国和 国际吧

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul John Norman其他文献

Paul John Norman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul John Norman', 18)}}的其他基金

Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere
东半球免疫遗传多样性的演变和功能
  • 批准号:
    10663162
  • 财政年份:
    2022
  • 资助金额:
    $ 79.45万
  • 项目类别:
Natural Killer cells and the Immunogenetics of COVID-19
自然杀伤细胞和 COVID-19 的免疫遗传学
  • 批准号:
    10686171
  • 财政年份:
    2021
  • 资助金额:
    $ 79.45万
  • 项目类别:
Natural Killer cells and the Immunogenetics of COVID-19
自然杀伤细胞和 COVID-19 的免疫遗传学
  • 批准号:
    10477389
  • 财政年份:
    2021
  • 资助金额:
    $ 79.45万
  • 项目类别:
Natural Killer cells and the Immunogenetics of COVID-19
自然杀伤细胞和 COVID-19 的免疫遗传学
  • 批准号:
    10297139
  • 财政年份:
    2021
  • 资助金额:
    $ 79.45万
  • 项目类别:
Control of Cytotoxic Lymphocytes by Polymorphic KIR3DL3
多态性 KIR3DL3 控制细胞毒性淋巴细胞
  • 批准号:
    10469872
  • 财政年份:
    2021
  • 资助金额:
    $ 79.45万
  • 项目类别:
Insights Into Immune-Related Diseases Born from Population Genomics
对群体基因组学产生的免疫相关疾病的见解
  • 批准号:
    10449317
  • 财政年份:
    2010
  • 资助金额:
    $ 79.45万
  • 项目类别:
Insights Into Immune-Related Diseases Born from Population Genomics
对群体基因组学产生的免疫相关疾病的见解
  • 批准号:
    10656300
  • 财政年份:
    2010
  • 资助金额:
    $ 79.45万
  • 项目类别:
Insights Into Immune-Related Diseases Born from Population Genomics
对群体基因组学产生的免疫相关疾病的见解
  • 批准号:
    10208683
  • 财政年份:
    2010
  • 资助金额:
    $ 79.45万
  • 项目类别:

相似海外基金

Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
  • 批准号:
    10818088
  • 财政年份:
    2023
  • 资助金额:
    $ 79.45万
  • 项目类别:
Admixture Mapping of Coronary Heart Disease and Associated Metabolomic Markers in African Americans
非裔美国人冠心病和相关代谢组标记物的混合图谱
  • 批准号:
    10571022
  • 财政年份:
    2023
  • 资助金额:
    $ 79.45万
  • 项目类别:
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil
美国和巴西不同群体神经病理特征的全基因组测序和混合分析
  • 批准号:
    10590405
  • 财政年份:
    2023
  • 资助金额:
    $ 79.45万
  • 项目类别:
NSF Postdoctoral Fellowship in Biology: Coalescent Modeling of Sex Chromosome Evolution with Gene Flow and Analysis of Sexed-versus-Gendered Effects in Human Admixture
NSF 生物学博士后奖学金:性染色体进化与基因流的合并模型以及人类混合中性别与性别效应的分析
  • 批准号:
    2305910
  • 财政年份:
    2023
  • 资助金额:
    $ 79.45万
  • 项目类别:
    Fellowship Award
Admixture mapping of mosaic copy number alterations for identification of cancer drivers
用于识别癌症驱动因素的马赛克拷贝数改变的混合图谱
  • 批准号:
    10608931
  • 财政年份:
    2022
  • 资助金额:
    $ 79.45万
  • 项目类别:
Leveraging the Microbiome, Local Admixture, and Machine Learning to Optimize Anticoagulant Pharmacogenomics in Medically Underserved Patients
利用微生物组、局部混合物和机器学习来优化医疗服务不足的患者的抗凝药物基因组学
  • 批准号:
    10656719
  • 财政年份:
    2022
  • 资助金额:
    $ 79.45万
  • 项目类别:
The role of admixture in human evolution
混合物在人类进化中的作用
  • 批准号:
    10683318
  • 财政年份:
    2022
  • 资助金额:
    $ 79.45万
  • 项目类别:
Genealogical ancestors, admixture, and population history
家谱祖先、混合和人口历史
  • 批准号:
    2116322
  • 财政年份:
    2021
  • 资助金额:
    $ 79.45万
  • 项目类别:
    Standard Grant
Genetic & Social Determinants of Health: Center for Admixture Science and Technology
遗传
  • 批准号:
    10307040
  • 财政年份:
    2021
  • 资助金额:
    $ 79.45万
  • 项目类别:
Admixture analysis of acute lymphoblastic leukemia in African American children: the ADMIRAL Study
非裔美国儿童急性淋巴细胞白血病的混合分析:ADMIRAL 研究
  • 批准号:
    10307680
  • 财政年份:
    2021
  • 资助金额:
    $ 79.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了